Metsä Board Oyj (METSA.HE)

Revenue growth under 50% of VALMT.HE's 19.67%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.

Negative gross profit growth while VALMT.HE is at 16.03%. Joel Greenblatt would examine cost competitiveness or demand decline.

EBIT growth below 50% of VALMT.HE's 60.00%. Michael Burry would suspect deeper competitive or cost structure issues.

Operating income growth under 50% of VALMT.HE's 60.00%. Michael Burry would be concerned about deeper cost or sales issues.

Net income growth under 50% of VALMT.HE's 50.00%. Michael Burry would suspect the firm is falling well behind a key competitor.

Negative EPS growth while VALMT.HE is at 50.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while VALMT.HE is at 50.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

Share count expansion well above VALMT.HE's 0.09%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.

Diluted share count expanding well above VALMT.HE's 0.09%. Michael Burry would fear significant dilution to existing owners' stakes.

No Data available this quarter, please select a different quarter.

Negative 10Y revenue/share CAGR while VALMT.HE stands at 49.95%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.

Negative 5Y CAGR while VALMT.HE stands at 49.95%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Negative 3Y CAGR while VALMT.HE stands at 43.07%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

10Y OCF/share CAGR at 50-75% of VALMT.HE's 444.44%. Martin Whitman might fear a structural deficiency in operational efficiency.

Below 50% of VALMT.HE's 444.44%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.

Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.

Below 50% of VALMT.HE's 1700.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.

Negative 5Y net income/share CAGR while VALMT.HE is 1700.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.

3Y net income/share CAGR 50-75% of VALMT.HE's 157.14%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.

No Data available this quarter, please select a different quarter.

Below 50% of VALMT.HE's 38.08%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

3Y dividend/share CAGR at 50-75% of VALMT.HE's 200.00%. Martin Whitman might see a weaker short-term approach to distributing cash.

AR growth of 9.45% while VALMT.HE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.

Inventory is declining while VALMT.HE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.

Negative asset growth while VALMT.HE invests at 2.05%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.

We have a declining book value while VALMT.HE shows 3.69%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.

We’re deleveraging while VALMT.HE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.

SG&A growth well above VALMT.HE's 7.09%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.